Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Infectious Disease · Disseminated Sporotrichosis

What Are the Risk Factors for Disseminated Sporotrichosis?

At a Glance

People with weakened immune systems from conditions like diabetes, HIV/AIDS, immunosuppressive medications, or heavy alcohol use are at the highest risk for severe disseminated sporotrichosis. In these patients, the fungal infection can escape the skin and spread to the bones, joints, lungs, or brain.

In this answer

3 sections

01

How Your Immune System Affects the Infection

02

Where the Infection Can Spread

03

Warning Signs and Strict Monitoring

Certain underlying health conditions, such as diabetes, can put you at a higher risk for a more severe or disseminated (widespread) sporotrichosis infection [1]. A weakened immune system—whether from uncontrolled diabetes, HIV/AIDS, taking immunosuppressive medications, or heavy alcohol use—impairs your body’s ability to contain the fungus at the site of the initial skin infection (usually a painless bump or sore) [2][3]. This impairment allows the fungus to escape into the bloodstream and spread to other areas of the body, such as the bones, joints, lungs, or central nervous system [4][5].

While disseminated sporotrichosis is relatively rare, knowing the risks and warning signs is important for anyone with a vulnerable immune system [4].

How Your Immune System Affects the Infection

In a healthy immune system, white blood cells quickly surround the Sporothrix fungus and keep it walled off in the skin [2]. However, underlying health conditions can disrupt this natural defense system:

  • Diabetes: High blood sugar levels and chronic inflammation impair the function of your white blood cells, making them less effective at fighting off fungal invaders [6][1].
  • HIV/AIDS: This virus directly attacks the immune cells that are essential for controlling fungal infections, leading to a higher risk of severe, widespread disease [7].
  • Immunosuppressive Medications: Drugs used to treat autoimmune diseases, prevent organ rejection, or manage severe inflammation (such as corticosteroids or biologic therapies) intentionally suppress the immune system, leaving the body more vulnerable [8][9].
  • Heavy Alcohol Use: Chronic alcohol consumption disrupts the body’s natural immune responses and increases inflammation, further weakening your ability to fight off infections [10].

Where the Infection Can Spread

When the immune system cannot contain the fungus, the infection can progress from a localized skin issue to extracutaneous (outside the skin) or disseminated sporotrichosis [11]. If this happens, the spread can cause complications in several areas:

  • Bones and Joints: This is one of the most common places for the infection to spread, leading to chronic arthritis, bone infections (osteomyelitis), and painful, swollen joints [12][13].
  • Lungs: The fungus can reach the lungs, causing symptoms that mimic tuberculosis, including chronic cough and structural lung damage [14].
  • Central Nervous System: In severely immunocompromised patients, the infection can cross into the brain and spinal cord, causing dangerous inflammation (meningitis) [15][16].

Warning Signs and Strict Monitoring

If you have an underlying condition like diabetes, strict monitoring of your health is essential [7]. Working with your healthcare team to actively manage your underlying conditions, such as keeping blood glucose levels in your target range, helps support your immune system’s ability to fight the infection [6].

Fortunately, highly effective antifungal therapies are available. Early detection and prompt treatment are critical to preventing a localized skin infection from becoming a severe, widespread infection [17][18].

You should contact your doctor immediately if you develop any of the following warning signs:

  • Joint pain, swelling, or stiffness, especially in large joints like knees, elbows, or wrists.
  • Fever, chills, or night sweats, which can indicate the fungus has entered your bloodstream.
  • Breathing issues, such as a persistent cough, shortness of breath, or chest pain.
  • New skin lesions or bumps that appear far away from the original site of infection.

Common questions in this guide

Why does sporotrichosis spread to other parts of the body?
In people with weakened immune systems, the body's white blood cells are unable to contain the Sporothrix fungus at the original skin infection site. This allows the fungus to escape into the bloodstream and travel to other areas like the bones, lungs, or central nervous system.
What health conditions increase the risk of severe sporotrichosis?
Conditions that compromise your immune system significantly increase your risk of a widespread infection. Major risk factors include uncontrolled diabetes, HIV/AIDS, heavy alcohol use, and taking immunosuppressive medications for autoimmune diseases.
What are the warning signs of disseminated sporotrichosis?
Warning signs that the infection is spreading include unexplained fevers, chills, night sweats, new joint pain or swelling, persistent cough, and new skin lesions appearing far from the original sore. Contact your doctor immediately if you develop any of these symptoms.
How does diabetes affect a sporotrichosis infection?
High blood sugar levels and chronic inflammation from uncontrolled diabetes impair the function of your white blood cells. This makes your immune system less effective at fighting off the fungal invaders, leaving you more vulnerable to a severe, widespread infection.
Where in the body can severe sporotrichosis spread?
When sporotrichosis becomes severe and spreads beyond the skin, it most commonly affects the bones and joints, leading to arthritis or bone infections. It can also spread to the lungs, causing tuberculosis-like symptoms, or cross into the central nervous system to cause meningitis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should I adjust my diabetes management plan or medications while fighting this infection?
  2. 2.What specific signs should prompt me to go to the emergency room versus calling the clinic?
  3. 3.Which antifungal medication is most appropriate for me given my other underlying health conditions?
  4. 4.How frequently will we monitor my progress, and will I need blood tests to check my liver or kidney function during treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Sporotrichosis Affect the Eyes?Can Sporotrichosis Mimic Squamous Cell Skin Cancer?Can Sporotrichosis Spread to Bones and Joints?Can You Catch Sporotrichosis From a Cat?Does Fluconazole or OTC Cream Treat Sporotrichosis?Does Sporotrichosis Cause Permanent Scarring?Does Sporotrichosis Respond to Antibiotics?How Long Does a Sporotrichosis Fungal Culture Take?How Long Is Sporotrichosis Treatment?Is Sporotrichosis Contagious from Person to Person?What Are Itraconazole Side Effects for Sporotrichosis?What Is the Incubation Period for Sporotrichosis?What Skin Infections Look Like Sporotrichosis?

References

References (18)
  1. 1

    Novel Insights into Sporotrichosis and Diabetes.

    Oliveira MA, de Almeida SR, Martins JO

    Journal of fungi (Basel, Switzerland) 2024; (10(8)) doi:10.3390/jof10080527.

    PMID: 39194853
  2. 2

    [Disseminated cutaneous sporotrichosis with joint involvement in a woman with type 2 diabetes].

    Solorzano S, Ramirez R, Cabada MM, et al.

    Revista peruana de medicina experimental y salud publica 2015; (32(1)):187-90.

    PMID: 26102124
  3. 3

    Palate ulcer, uvular destruction and nasal septal perforation caused by Sporothrix brasiliensis in an HIV-infected patient.

    Eyer-Silva WA, de Azevedo MCVM, da Silva GAR, et al.

    Medical mycology case reports 2019; (23()):16-19 doi:10.1016/j.mmcr.2018.11.001.

    PMID: 30479942
  4. 4

    Chronic Meningitis and Hydrocephalus due to Sporothrix brasiliensis in Immunocompetent Adults: A Challenging Entity.

    Mialski R, de Almeida JN, da Silva LH, et al.

    Open forum infectious diseases 2018; (5(5)):ofy081 doi:10.1093/ofid/ofy081.

    PMID: 29977951
  5. 5

    A rare case of disseminated Sporothrix schenckii with bone marrow involvement in a patient with idiopathic CD4 lymphocytopenia.

    Yagnik KJ, Skelton WP, Olson A, et al.

    IDCases 2017; (9()):70-72 doi:10.1016/j.idcr.2017.06.012.

    PMID: 28706855
  6. 6

    Cryosurgery as adjuvant treatment for cutaneous sporotrichosis in two patients with diabetes mellitus type 2.

    Robles-Tenorio A, Rocha-Mendez LE, Tarango-Martinez VM

    Clinical and experimental dermatology 2023; (48(3)):257-259 doi:10.1093/ced/llac090.

    PMID: 36763769
  7. 7

    Zoonotic sporotrichosis in renal transplant recipients from Rio de Janeiro, Brazil.

    Fichman V, Marques de Macedo P, Francis Saraiva Freitas D, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2021; (23(2)):e13485 doi:10.1111/tid.13485.

    PMID: 33012063
  8. 8

    Management of sporotrichosis in patients with inflammatory bowel disease using biological therapy (antitumor necrosis factor).

    Godoy Finger AP, Tavares Ferreira de Oliveira Cruz L, Rosevics L, et al.

    European journal of gastroenterology & hepatology 2025; (37(3)):370-375 doi:10.1097/MEG.0000000000002907.

    PMID: 39919009
  9. 9

    Extracutaneous Sporotrichosis With Dissemination to the Brain in a Patient Taking Biologic Medications: A Case Report.

    Nguyen KN, Defreitas D, Youree B, Gautam S

    Cureus 2025; (17(10)):e95847 doi:10.7759/cureus.95847.

    PMID: 41328145
  10. 10

    Transcriptional and Epigenetic Regulation of Monocyte and Macrophage Dysfunction by Chronic Alcohol Consumption.

    Malherbe DC, Messaoudi I

    Frontiers in immunology 2022; (13()):911951 doi:10.3389/fimmu.2022.911951.

    PMID: 35844518
  11. 11

    Bone sporotrichosis: 41 cases from a reference hospital in Rio de Janeiro, Brazil.

    Ramos V, Astacio GS, do Valle ACF, et al.

    PLoS neglected tropical diseases 2021; (15(3)):e0009250 doi:10.1371/journal.pntd.0009250.

    PMID: 33730026
  12. 12

    Variability of clinical presentation and diagnostic challenges in osteoarticular sporotrichosis: a case series.

    Oliveira RDR, Martinez R, Gaspar GG, et al.

    Revista do Instituto de Medicina Tropical de Sao Paulo 2026; (68()):e3 doi:10.1590/S1678-9946202668003.

    PMID: 41637342
  13. 13

    Differences in epidemiological and clinical findings between localized and systemic osteoarticular infection caused by Sporothrix: A systematic review of individual participant data.

    Ramírez-Soto MC, Bonifaz A, Tirado-Sánchez A, et al.

    Medical mycology 2025; (63(10)) doi:10.1093/mmy/myaf088.

    PMID: 40973070
  14. 14

    Pulmonary Sporotrichosis: An Evolving Clinical Paradigm.

    Aung AK, Spelman DW, Thompson PJ

    Seminars in respiratory and critical care medicine 2015; (36(5)):756-66 doi:10.1055/s-0035-1562901.

    PMID: 26398541
  15. 15

    Clinical characteristics, diagnosis, and treatment of central nervous system sporotrichosis: Systematic review and meta-analysis.

    de Oliveira VF, Petrucci JF, Taborda M, et al.

    Mycoses 2024; (67(2)):e13697 doi:10.1111/myc.13697.

    PMID: 38374494
  16. 16

    Disseminated sporotrichosis caused by Sporothrix brasiliensis with testicular involvement.

    Cognialli RCR, Taborda MH, Carneiro BH, et al.

    Medical mycology case reports 2025; (49()):100716 doi:10.1016/j.mmcr.2025.100716.

    PMID: 40677965
  17. 17

    Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis.

    Marques de Macedo P, Sturny-Leclère A, Freitas DFS, et al.

    Medical mycology 2023; (61(7)) doi:10.1093/mmy/myad063.

    PMID: 37491705
  18. 18

    Detection of Sporothrix brasiliensis in Human Tissue by Direct PCR Using Species-Specific Primers and NESTED PCR in a New Epidemic Area of Sporotrichosis.

    de Freitas JF, da Silva Barbosa G, Luiz RLF, et al.

    Mycopathologia 2025; (190(5)):74 doi:10.1007/s11046-025-00986-y.

    PMID: 40828486

This page provides educational information about the risk factors and complications of severe disseminated sporotrichosis. It does not replace professional medical advice; always consult your healthcare provider immediately if you suspect an infection is spreading.

Get notified when new evidence is published on Sporotrichosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.